Drugs Market Research Reports
The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
The industry report Database of the Top Pharmaceutical Preparation Producers in the World - Company Names, Financial Performance, Key Executives, and Contact Details offers the most up-to-date perspective on pharmaceutical preparation producers in the world. The report includes details for nearly 1000 ...
Jun, 2013... a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers” is a unique study designed to help current suppliers ...
Jun, 2013 300 pages... for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in the US: Hospitals, Commercial Labs, Physician Offices” is a unique study designed to help current suppliers and potential market ...
Jun, 2013 262 pages... resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace ... , such as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in the UK: Hospitals and Commercial Labs” is a unique study ...
Jun, 2013 260 pages... of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers” is a unique study designed to help current suppliers and potential market entrants ...
Jun, 2013 260 pages... shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for ... as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in Japan: Hospitals and Commercial Labs” is a unique study designed ...
Jun, 2013 260 pages... shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for ... as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in Italy: Hospitals and Commercial Labs” is a unique study designed ...
Jun, 2013 260 pages... of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in Germany: Hospitals, Commercial Labs, Physician Offices” is a unique study designed to help current suppliers and potential market entrants ...
Jun, 2013 262 pages... shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for ... as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in France: Hospitals and Commercial Labs” is a unique study designed ...
Jun, 2013 260 pages... Group contains 14 tables, and provides a comprehensive analysis of the POC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory ... . Five-year test volume and reagent sales forecasts for drugs of abuse procedures by market segment: Physician Offices/Group Practices Emergency ...
May, 2013 165 pages... Acid and Vancomycin. During the next five years, the TDM market will undergo significant transformation. These changes will be caused ... as specimen preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in the US: Hospitals, Commercial Labs, Physician Offices” ...
Jun, 2013 249 pages... as specimen preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in the UK: Hospitals and Commercial Labs” is a unique ... responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors ...
Jun, 2013 247 pages... preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers” ... responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors. ...
Jun, 2013 249 pages... preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in Japan: Hospitals and Commercial Labs” is a unique market and ... responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors. ...
Jun, 2013 247 pages... preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in Italy: Hospitals and Commercial Labs” is a unique market and ... responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors. ...
Jun, 2013 247 pages... Acid and Vancomycin. During the next five years, the TDM market will undergo significant transformation. These changes will be caused ... preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in Germany: Hospitals, Commercial Labs, Physician Offices” is a unique ...
Jun, 2013 249 pages... preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in France: Hospitals and Commercial Labs” is a unique market and ... responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors. ...
Jun, 2013 247 pages... Acid and Vancomycin. During the next five years, the TDM market will undergo significant transformation. These changes will be caused ... as specimen preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in the US: Hospitals, Commercial Labs, Physician Offices, ...
Jun, 2013 291 pages... positive chronic myeloid leukaemia, optionally in combination with erythropoietin, G-CSF, hydroxyurea or Anagrelide Nilotinib innovator: Novartis (Tasigna) Examples of information found in this online report include: Includes key patent publications for 7 countries (see list below) Contains SPC protection ...
Jun, 2013... , by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff ... the world's key territories (see 'search coverage' below) Identifies patents covering molecule, formulation, process, use, combination and assay techniques ( ...
Jun, 2013... and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Nilotinib Nilotinib indications: Treatment of Philadelphia chromosome positive chronic myeloid leukaemia, optionally in combination with erythropoietin, ...
Jun, 2013... non-transfusion dependent thalassaemia; Management of chronic iron overload in transfusion-dependent anaemias Deferasirox innovator: Novartis (Exjade) Examples of information found in this online report include: Includes key patent publications for 7 countries (see list below) Contains SPC protection for ...
Jun, 2013... non-transfusion dependent thalassaemia; Management of chronic iron overload in transfusion-dependent anaemias Deferasirox innovator: Novartis (Exjade) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection ...
Jun, 2013... , by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff ... the world's key territories (see 'search coverage' below) Identifies patents covering molecule, formulation, process, use, combination and assay techniques ( ...
Jun, 2013... report covers Ceftolozane Ceftolozane indications: Treatment of serious Gram-negative bacterial infections Ceftolozane innovator: Cubist Examples of information found in this online report include: Includes key patent publications for 7 countries (see list below) Contains SPC protection for every EU ...
Jun, 2013... report covers Ceftolozane Ceftolozane indications: Treatment of serious Gram-negative bacterial infections Ceftolozane innovator: Cubist Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU ...
Jun, 2013... , by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff ... the world's key territories (see 'search coverage' below) Identifies patents covering molecule, formulation, process, use, combination and assay techniques ( ...
Jun, 2013... Ceftobiprole Ceftobiprole indications: Treatment for complicated skin and skin structure infections Ceftobiprole innovator: Janssen (Zeftera, Zevtera) Examples of information found in this online report include: Includes key patent publications for 7 countries (see list below) Contains SPC protection ...
Jun, 2013... Ceftobiprole Ceftobiprole indications: Treatment for complicated skin and skin structure infections Ceftobiprole innovator: Janssen (Zeftera, Zevtera) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection ...
Jun, 2013... , by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff ... the world's key territories (see 'search coverage' below) Identifies patents covering molecule, formulation, process, use, combination and assay techniques ( ...
Jun, 2013... complicated intra-abdominal infections and complicated urinary tract infections in combination with Ceftazidime or Ceftaroline Avibactam innovator: Examples of information found in this online report include: Includes key patent publications for 7 countries (see list below) Contains SPC protection for ...
Jun, 2013... complicated intra-abdominal infections and complicated urinary tract infections in combination with Ceftazidime or Ceftaroline Avibactam innovator: Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for ...
Jun, 2013... , by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff ... the world's key territories (see 'search coverage' below) Identifies patents covering molecule, formulation, process, use, combination and assay techniques ( ...
Jun, 2013... brand images. Compared with that of countries with advanced medicine levels, China OTC drug industry is featured by late start, fast growth and ... or occupy market by regional advantages. With the standardizing development of domestic OTC drug market and the increase in residents' healthcare consciousness, the ...
May, 2013 30 pages... five years, from 2012-2017, will see the launch of many new drugs. Scope of the Report The Alzheimer’s drug market (2011-2017) ... III clinical trials. Chapter 8 provides profiles of the key companies in this market. Each company profile includes information such as financial performance, geographical ...
Oct, 2012 117 pages... patent expiries could pose a challenge to the growth of this market. TechNavio's report, the Global Alzheimer's Drugs market 2012-2016, has been prepared based on an ... Drugs market in the Americas, the EMEA, and the APAC regions, its market landscape, and growth prospects in the coming years. The report also ...
May, 2013 51 pages... as extensive listings of companies developing and marketing innovative technologies and products. This report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, new ...
May, 2013 549 pages... shares) $5,500. This new 313-page report from Venture Planning Group contains 83 tables and provides analysis of the global therapeutic ... as specimen preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market: US, Europe (France, Germany, Italy, Spain, UK), Japan” ...
May, 2013 313 pages... shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for ... , such as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan” ...
May, 2013 318 pages... and royalties by stage of development Antibiotics partnering contract documents Top antibiotics deals by value The Antibiotics Partnering Terms and Agreements report provides an ... How aresalesand payments audited? What is the deal term? How are the key terms of the agreement defined? How are IPRs handled ...
May, 2013 340 pages... their dynamics, trends, structure, size, growth and major suppliers. Five-year test volume and reagent sales forecasts for drugs of ... Offices/Group Practices Emergency Rooms Ambulatory Care Centers Analysis of drugs of abuse procedures Competitive Assessments Assessments of major POC suppliers and ...
May, 2013 194 pagesThis report analyzes the worldwide markets for Ion Channel Modulators in US$ Million. The report provides separate comprehensive analytics for the US, ... Ltd., Renesas Electronics Corporation, VIA Technologies, Inc., and Zilog, Inc. Market data and analytics are derived from primary and secondary research. ...
Mar, 2013 404 pages... vendors could pose a challenge to the growth of this market. TechNavio's report, Global Proteomics Market 2012-2016, has been prepared based on an in-depth market ... . The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this space are Thermo Fischer ...
Apr, 2013 44 pages... the end of the review period, all triptans remained Rx in Kazakhstan. Euromonitor International's OTC Triptans in Kazakhstan report offers a comprehensive guide to the ... data. Why buy this report? Get a detailed picture of the OTC Triptans market; Pinpoint growth sectors and identify factors driving ...
Apr, 2013 16 pages... suffering from migraines if this diagnosis is approved. Euromonitor International's OTC Triptans in Azerbaijan report offers a comprehensive guide to the size and shape of ... data. Why buy this report? Get a detailed picture of the OTC Triptans market; Pinpoint growth sectors and identify factors driving ...
Apr, 2013 16 pagesEmergency contraception products in Kazakhstan are Rx, since they might be overused, particularly by younger consumers. Euromonitor International's Emergency Contraception in Kazakhstan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail ...
Apr, 2013 16 pagesChina's demand for alzheimer disease treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry ...
Apr, 2013 207 pagesChina's demand for prescription drugs has grown at a fast pace in the past decade. In the next five years, both production and demand ... environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and ...
Apr, 2013 192 pages... Squibb Novartis Pfizer Sanofi As indicted in the study, the thrombotic drugs segment is currently small, but holds great growth potential in the ... industry leaders with a competitive benchmarking of the world’s top five cardiovascular drugs companies. The study provides up-to-date information on the market ...
Dec, 2012
